Tiziana Life Sciences Share Discussion Threads

[stenick] 20/7/2018 13:46

End statement of Oncgene article

As presented in this study, JQ1 and Milciclib suppress MYC in different ways, causing a synergistic inhibition rather than an additive repression. We therefore propose using these inhibitors in combination for treating MYC-dependent, aggressive pediatric brain tumors.

[stenick] 20/7/2018 13:30

Now that I can’t answer.
But luckily I’m still in for free as I managed to buy low and sell some,and I can’t walk away from this with so much good reasearch done on Milciclib.
I’ve actually read the study report on the brain tumours with JQ1 and Milciclib combo and it actually says it Destroys the tumour and it won’t return.
I know aim is a gamble, but I have to believe scientific studies, So I’ll wait and see happens.
Sorry to here about your tumour hope all is well.
Btw JQ1 was bought recently for $12billion but it works better with Milciclib apparently.

[jpuff] 20/7/2018 12:49

Also, as you elude to - if so good and successful why no interest what so ever from traders or a bidding war here?

[jpuff] 20/7/2018 12:48

I sincerely hope you are right Stenick. Having been operated on nearly five years ago with a brain tumour the size of a satsuma I would welcome progress there myself. I guess I'm just bitter about buying at the exact wrong time their previous broker was peddling buy notes at the very peak!

[stenick] 20/7/2018 09:26

Maybe jpuff. But the financial statement said Mr. Cerrone sees no funding problems for the foreseeable future, and the trials are funded too.
Which is very confusing.
Also they keep awarding options and referring to a change of ownership, so maybe a buyout is on the cards.
The reference to JO1 and Milciclib combination being extremely effective against brain tumours is amazing. It seems whoever ends up with Milciclib will be very rich.
I suspect they will have good results with combination with Bayer drug.

[jpuff] 20/7/2018 08:30

Maybe competitors think the company are going to run out of cash at which point they buy the IP from the administrators etc? No trades at all it appears in this company so trying to sell would be pointless due to illiquidity and at this level pointless too! So we are stuck with fingers crossed wishing we'd never had bankrupt broker Beauforts (crooks) do the hard sell on ordinary small investors at 220p saying it was a "buy". The only recourse is hope and prayers or possibly the FSCS. Something is only worth what someone is willing to pay for I guess is the short answer.

[stenick] 19/7/2018 18:45

Can someone please explain why loads of money is pumped into a drug and it ends up with excellent results and is ignored ?

[stenick] 17/7/2018 11:45

News that I didn’t know already.
.thebraintumourcharity.org/media-centre/news/latest-news/combination-therapy-treat-medulloblastoma/

[stenick] 05/7/2018 16:37

It’s all these algoritham trades, roll on one bit of news we don’t know already.

[asmodeus] 05/7/2018 11:30

TILS UP! (12.9%, at 11.30 am)

[stenick] 20/6/2018 18:43

Nice one Asmodeus, Lol. Can’t wait for AGM.
I’m waiting for news of Bayer drug trial combo to jump in again.

[jpuff] 20/6/2018 17:29

TILS up is something that simply doesn't happen!

[jpuff] 20/6/2018 16:54

Going down the swanny or t*ts up? Any other view?

[jpuff] 14/6/2018 13:51

Who ever goes, let them know that I along with everyone else are astonished by the share price collapse without a word said by the company!

[stenick] 14/6/2018 12:48

AGM soon, I wonder if we will get any news. Anyone going to TILS AGM?

[stenick] 14/6/2018 12:46

I don’t think the RGT shareholders will get anything, raising hopes does no good. So please only TILS here.

[asmodeus] 13/6/2018 22:11

Which Epicode should we use, Gen - if that's what you mean? (good to hear from you) Asmo.

[genises] 13/6/2018 15:30

Full update for RGt shareholders released today tap in News in epic which will take you to the news

[stenick] 12/6/2018 10:16

Don’t know, perhaps people got fed up with waiting, cancer research does take an awfull long time, but IMO nothing has really changed in that they are still on course with very good products. Timescales are a bit out, but that’s ‘par for the course’. All I see is a good buying opportunity.
Also we still have no idea what Beauforts had been upto.

[jpuff] 12/6/2018 08:07

So why the collapse in share price?

[stenick] 12/6/2018 08:03

I think you’ll find they have about £4.2 million for this year already.

[jpuff] 11/6/2018 21:40

And to think their broker only last year Beauforts were pushing out BUY notes at 240p! Didn't they know the dire straits the company were in at the time? Oh yes they did go bump themselves recently and have been charged with pump and dump activities in the USA , hmmm very fishy eh.

[genises] 11/6/2018 21:22

Jpuff
Look at the accounts
No money left which means more fundraising at a discount 40p+

[jpuff] 11/6/2018 20:34

Ok, I didn't realise that. Looks like we are all being unfortunate now (deja vu for you?). Why the collapse in share price for TILS from 240p to 56p with no mention or explanation from company? Is this a lost cause now or what in your opinion? Cheers